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Natural restricted dietBackground: In phenylketonuria, dietary treatment prevents most of the severe brain disease. However, patients
have to follow a diet restricted in several natural components, what may cause decreased bone density and
obesity. Exercise is known to improve both mental functioning and bone density also avoiding obesity, and
could optimize aspects of central and peripheral outcome, regardless changes in phenylalanine (Phe) levels.
However, the acute effects of exercise on metabolic parameters in phenylketonuria patients are unknown and
thereby long-term adaptations are unclear. Therefore, this study aimed to evaluate patients' basal metabolic
rate (BMR), and their acute response to an aerobic exercise session on plasma concentrations of Phe, tyrosine
(Tyr), and branched-chain amino acids (BCAA), as well as metabolic and hormonal responses.
Methods: Five early- and four late diagnosed phenylketonuria patients aged 21 ± 4 years and 17 sex-, age-, and
BMI-matched controlswere evaluated for BMR, peak oxygen consumption (VO2peak) and plasma amino acid, glu-
cose, lipid proﬁle and hormonal levels. At least oneweek later, participants performed a 30-min aerobic exercise
session (intensities individually calculated using theVO2peak results). Blood sampleswere collected in fasted state
(moment 1, M1) and immediately after a small breakfast, which included the metabolic formula for patients but
not for controls, and the exercise session (moment 2, M2).
Results: Phenylketonuria patients and controls showed similar BMR and physical capacities. At M1, patients pre-
sented higher Phe concentration and Phe/Tyr ratio; and lower levels of BCAA and total cholesterol than controls.
Besides that, poorly controlled patients tended to stay slightly below the prescribed VO2 during exercise. Both pa-
tients and controls showed increased levels of total cholesterol and LDL at M2 compared with M1. Only controls
showed increased levels of Tyr, lactate, and HDL; and decreased Phe/Tyr ratio and glucose levels atM2 compared
to values at M1.
Conclusions: Acute aerobic exercise followed by a Phe-restricted breakfast did not change Phe concentrations in
treated phenylketonuria patients, but it was associated with decreased Phe/Tyr only in controls. Further studies
are necessary to conﬁrm our results in a higher number of patients.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).I, body mass index; BMR, basal
n; LDL, low-density lipoprotein;
ne; PKU, phenylketonuria; RER,
ioxide production; VO2, oxygen






. This is an open access article under1. Introduction
Phenylketonuria (PKU, MIM 261600) is an autosomal recessive dis-
ease characterized by high levels of phenylalanine (Phe) in plasma and
brain, due to the low activity of Phe hydroxylase (PAH, EC 1.14.16.1),
which converts Phe into tyrosine (Tyr). Currently, patients are diagnosed
by newborn screening programs and are treated with a Phe-restricted
diet. Although mental retardation can be prevented with early diagnosis
and dietary treatment, some peripheral and neurological problems re-
main. Regarding brain status, patients have shown non-optimal neuro-
psychological outcome with decreased capacity especially in executivethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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turbances [5,6]. On the peripheral level, decreased bone density [7–9]
and increased risk of overweight [10,11] are also reported in treated
PKU patients. As yet, it is not clear whether these problems are due to
the high blood Phe concentrations or to the dietary treatment restricting
not only Phe, but also other important micronutrients. Moreover, a wide
range of protein-rich foods are forbidden thus daily caloric needs are ful-
ﬁlled with carbohydrates and lipids [10].
Exercisemay represent a treatment strategy in PKU since it has been
proven to enhance overall health in different populations. In healthy in-
dividuals, regular exercise improvesmood and cognition [12], decreases
depressive symptoms [13], decreases the risk of obesity [14], and im-
proves bone density [15,16]. Moreover, physical training leads to better
neurological outcomes in patients with neurodegenerative diseases
[17,18], and mild cognitive impaired elderly [19]. Therefore, PKU
patients might also beneﬁt from the exercise-induced adaptations.
High plasma Phe alongwith the Phe-restricted dietmay lead to differ-
ent metabolic responses to exercise in continuously treated PKU, what
could affect training adaptations [20]. Acutely, exercise increases themet-
abolic demand and protein turnover, which can affect amino acid levels
[21]. In addition, different dietary composition can alter themetabolic re-
sponse to exercise, leading to speciﬁc long-term adaptations [22]. So far,
only the study by Grünert et al. [23] has reported the effects of exercise
in PKU patients, suggesting aerobic exercise does not importantly affect
peripheral Phe levels in these patients. However, that study was not con-
trolled and had evaluated the pre- and post-exercise Phe and Tyr levels as
secondary objectives and in a relatively fasted state.
Therefore, the aimof this studywas to investigate the acute effects of




Participants performed two days of interventions (Fig. 1) at the
Laboratory of Physical Exercise (LAPEX), Federal University of Rio
Grande do Sul (UFRGS), Porto Alegre, Brazil. This study was carried
out in accordance with The Code of Ethics of theWorld Medical Associ-
ation (Declaration of Helsinki) for experiments involving humans. The
local Human Research Ethics Committee has approved the study
(N.120292 HCPA-UFRGS), and all participants (or parent/legal tutor
for patients younger than 18 years old) signed an informed consent
term before starting the tests.
2.2. Participants
Inclusion criteria were: (a) conﬁrmed diagnosis of classical PKU,
(b) following treatment regularly in a PKU Center in the south ofFig. 1. Experimental design. In fasted state, participants went to the lab twice (at day 0 and day
blood sampling for plasma phenylalanine (Phe) evaluation (0), breakfast and 30-min rest. Then
was collected atmoment 1 (M1), then participants received breakfast, waited 30-min in rest an
last blood sample was collected.Brazil, (c) aged N13 years, (d) not engaged in exercise training, and
(e) mentally and physically able to perform exercise. From a total of
16 invited patients, ﬁve did not agree to participate due to travel issues
and two because of personal reasons. Therefore, nine PKU patients from
the Medical Genetics Service — Hospital de Clínicas de Porto Alegre,
Brazil, were included. One patient did not follow the fasting require-
ment at day 1, so he was excluded from the exercise session results.
Healthy non-PKU subjects were sex- age- and BMI-matched in an ap-
proximately 1:2 ratio to patients, and were not engaged in exercise
training. The controlswere invited through banners and advertisements
in the University community.
Patients were classiﬁed as being early diagnosed (if the diagnosis
was performed before the end of the ﬁrst month of life) or late diag-
nosed (if the diagnosis was performed after the end of the ﬁrst month
of life), and were following treatment since diagnosis. Patients were
also classiﬁed as “well controlled” if their current Phe levels at M1
were below 700 μmol/L, or as “poorly controlled” if these levels were
equal or above 700 μmol/L. The treatment consisted of being on the
Phe-restricted diet (low Phe intake along with the metabolic formula).
2.3. BMR test
TheBMRwas determined in a 10–12h fasted state between 7.00 and
9.00 am at day 0 in order to assess daily basal caloric expenditure. The
participants stayed in supine position for 30 min while their expiratory
ventilationwas analyzed by an automated open-circuit gas analysis sys-
tem (MedGraphics Cardiorespiratory Diagnostic Systems,model CPX-D,
and using the method Breath by Breath). The expired air fractions of
oxygen consumption (VO2) and carbon dioxide production (VCO2)
were measured every minute during the last 20 min of the test. The
equation proposed by Weir [24], [(3.9 × VO2) + (1.1 × VCO2)], was
used to obtain the values in kcal/min, which were then transformed
into kcal/kg/day. Respiratory exchange ratio (RER) was also calculated
by the quotient between VCO2 and VO2.
2.4. Standard breakfasts
All participants received a standard breakfast (day 0) after the BMR
test and, at day 1, 30 min before the exercise session (Fig. 1). The PKU
breakfast consisted of a banana, a rice cookie and 200 mL of water
mixed with two tablespoons of the metabolic formula (PKU 2 Secunda,
Milupa) andone tablespoon of crystal sugar. The controls also received a
banana and a rice cookie, but a regular yogurt (200 mL) instead of the
metabolic formula. Regarding nutritional facts, PKU patients received a
breakfast of 198 kcal and 40 mg of Phe (67% of carbohydrates, 30% of
protein — containing approximately 395 mg of tyrosine, 403 mg of iso-
leucine, 664 mg of leucine, and 470 mg of valine — and 3% of lipids),
while controls received a 157 kcal meal containing 340 mg of Phe
(80% of carbohydrates, 17% of proteins and 2% of lipids).1). In the day 0, participants performed the basal metabolic rate (BMR) test, followed by
the peak oxygen consumption (VO2peak) test was performed. In the day 1, blood sampling
d performed the aerobic exercise session. Immediately after exercise (moment 2, M2), the
Table 1
Clinical characteristics from control (CTL) and phenylketonuria (PKU) groups at day 0.
CTL PKU p value
Gender (male:female) 12:5 7:2 NS
Age (years) 22 ± 4 (17) 21 ± 4 (9) NS
BMI (kg/m2) 23 ± 2 (17) 24 ± 3 (9) NS
Phenylalanine (μmol/L) 57 ± 14 (17) 562 ± 141 (9) b0.001
BMR (kcal/kg/day) 21 ± 4 (17) 23 ± 4 (9) NS
RER during BMR 0.87 ± 0.07 (17) 0.82 ± 0.07 (9) NS
VO2peak (mL/kg/min) 31 ± 6 (17) 28 ± 8 (9) NS
Workload peak (W) 216 ± 49 (17) 203 ± 31 (9) NS
BMI, bodymass index, BMR, basal metabolic rate, RER, respiratory exchange ratio, VO2peak,
peak oxygen consumption, NS, non-signiﬁcant. Data for numeric variables are expressed
as mean ± SD (n). See methodology for details on the statistical analysis.
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VO2peak (mL/kg/min) was determined by an incremental stationary
cycling exercise test to the point of exhaustion [25,26], using the gas an-
alyzer described to the BMR test. This test was performed at day 0 of
evaluations, 30 min after the standard breakfast.
Regarding standard safety procedures, wemonitored for headaches,
dizziness, altered vision, heart rate and hematocrit levels during and
after exercise bouts (maximum test and aerobic session). A stationary
bicycle was used due to its safety even for those who were not used to
exercise. A cardiologist followed all the procedures.
2.6. Acute exercise protocol
Using the same ventilatory analyzer described to the BMR and
VO2peak tests, all participants performed 30 min of cycling exercise at a
prescribed VO2. The prescribed aerobic intensity was calculated for
each participant representing the VO2 value at 10% below the second
ventilatory threshold, which was assessed by the VO2peak test at least
one week earlier. The one-week interval was chosen to avoid possible
interferences of the maximum test on the submaximal exercise session,
especially for sedentary individuals.
The VO2 was tracked throughout the exercise bout and the partici-
pant was asked to keep his/her VO2 within the target zone (prescribed
VO2 ± 2 mL/kg/min). When the participant was below or above it,
he/she was encouraged to either increase or decrease the load or
speed to stay in his/her calculated aerobic zone. Values of prescribed-
and averaged actual VO2 during the exercise session were compared
and expressed as percentage of the prescribed VO2. Since executive
function of early and late diagnosed patients has shown to be affected
by current levels of Phe [2,27], the actual VO2 values were analyzed
with regard to Phe control in the group of patients.
2.7. Blood sampling
Blood collectionswere performed at day 0 after theBMR test in a 10–
12 h fasted state (for evaluation of Phe levels only), at day 1 in a 10–12 h
fasted condition, i.e. at moment 1 (M1), and immediately after the aer-
obic exercise bout, i.e. at moment 2 (M2) also having had the light
breakfast. The number of samples varied in some evaluations because
it was not possible to collect the same amount of blood from all
participants.
2.8. Biochemical measurements
Quantitative analysis of Phe, Tyr, and branched-chain amino acid
(BCAA, isoleucine, leucine, and valine) levels in plasma was carried
out by HPLC with ﬂuorescence detector [28] with an internal variation
coefﬁcient less than 3%.
Serumglucose, total cholesterol, HDL and triacylglycerol were deter-
mined by speciﬁc commercial kits for the automated analyzer Cobas
C111. The LDL value was estimated by the difference of total cholesterol
and HDL minus triacylglycerol divided by ﬁve.
Plasma adiponectinwas evaluated using a commercial kit for human
adiponectin (Invitrogen KHP0041) ELISA immunoassay. The catechol-
amines dopamine, noradrenaline and adrenaline were analyzed in
plasma by HPLC with electrochemical detection.
2.9. Statistical analysis
Data normality was tested by Shapiro–Wilk test. Control and PKU
groups were compared using the independent Student's t-test for
basal and M1 analyses, and with two-sided paired t-test for compari-
sons between M1 versus M2 in each group. Correlations were
performed using Spearman's correlation. Categorical variables were
compared by Fisher's Exact Test. SPSS 22.0 was employed for allstatistical analyses and a p b 0.002 was considered statically signiﬁcant
after applying Bonferroni correction.
3. Results
3.1. Sample characterization
The data of the nine PKU patients and 17 controls are described in
the Table 1. Five patients were early diagnosed and four patients were
late diagnosed. At day 0, Patients' current Phe concentrations varied
between 323 and 761 μmol/L.
3.1.1. BMR and VO2peak tests
Two controls, but no PKUpatient, experienced discomfort during the
protocols. Concerning basal status, PKU patients and controls showed
similar values of BMR and RER during the BMR test. In the same way,
patients showed similar aerobic capacity and workload peak in the
VO2peak test in comparison to controls (Table 1).
3.2. Exercise session
3.2.1. Baseline values at M1
In rest and fasted state, patients showed higher Phe levels and
Phe/Tyr ratio, and lower levels of BCAA and total cholesterol in compar-
ison to controls (Table 2). Phe levels ranged between 583 and 1029
μmol/L in the PKU group. Regarding Phe control at M1, ﬁve patients
showed good control. All early-diagnosed patients had good control of
Phe levels, while all late diagnosed patients had poor Phe control.
Accordingly, patients showed positive correlation between the age at
diagnosis and the Phe levels at M1 (r = 0.97; p b 0.001).
3.2.2. Ventilatory measurements during exercise
PKU patients and controls showed similar values of prescribed VO2
(21 ± 6 versus 22 ± 4mL/kg/min, respectively), and actual VO2 during
exercise (18 ± 5 versus 22 ± 4 mL/kg/min, respectively). Despite not
statistically different, poorly controlled patients showed the lowest
percentage of actual VO2 during exercise in relation to the prescribed
value (Fig. 2). Mean RER values during exercise were similar between
PKU and controls (0.99 ± 0.09 versus 0.96 ± 0.05, respectively).
3.2.3. Biochemical values at M2
Phe concentrations were not different between M1 and M2 in the
PKU as well as in the control group. In the PKU group, Phe concentra-
tions ranged between 490 and 984 μmol/L at M2. Phe/Tyr ratio was
lower at M2 than at M1 only in controls (Table 2). Total cholesterol,
LDL levels were increased at M2 in both PKU patients and controls in
comparison with M1 (Table 2). Only in controls, Tyr, lactate, and HDL
levels were higher, while glucose levels were lower at M2 in compari-
son with values at M1. Levels of BCAA, triacylglycerol, dopamine, nor-
adrenaline, adrenaline, and adiponectin were not modiﬁed between
M1 and M2 in patients and controls.
Table 2
Biochemical parameters at moments 1 (M1) and 2 (M2) in controls (CTL) and phenylketonuria (PKU) patients.
M1 CTL M1 vs PKU M1 M2 CTL M1 vs CTL M2 PKU M1 vs PKU M2
CTL PKU p value CTL PKU p value p value
Phe (μmol/L) 81 ± 24 (17) 773 ± 190 (8) b0.001 73 ± 15 (17) 723 ± 139 (8) NS NS
Tyr (μmol/L) 57 ± 15 (17) 62 ± 9 (8) NS 79 ± 20 (17) 90 ± 24 (8) b0.001 NS
Phe/Tyr ratio 1.4 ± 0.2 (17) 12.4 ± 2.4 (8) b0.001 1.0 ± 0.2 (17) 8.3 ± 1.8 (8) b0.001 NS
Tryptophan (μmol/L) 35 ± 9 (17) 29 ± 6 (8) NS 35 ± 8 (17) 36 ± 12 (8) NS NS
BCAA (μmol/L) 456 ± 86 (17) 332 ± 50 (8) 0.001 403 ± 63 (17) 478 ± 132 (8) NS NS
Glucose (mg/dL) 89 ± 8 (17) 83 ± 7 (8) NS 77 ± 9 (17) 78 ± 11 (8) 0.001 NS
Lactate (mg/dL) 1.3 ± 0.5 (17) 1.3 ± 0.3 (7) NS 3.7 ± 1.6 (17) 3.6 ± 1.8 (7) b0.001 NS
Triacylglycerol (mg/dL) 89 ± 33 (17) 76 ± 27 (8) NS 100 ± 39 (17) 77 ± 27 (8) NS NS
Total cholesterol (mg/dL) 168 ± 31 (17) 121 ± 26 (8) 0.001 181 ± 34 (17) 129 ± 26 (8) b0.001 b0.001
HDL (mg/dL) 54 ± 12 (17) 42 ± 6 (8) NS 57 ± 11 (17) 45 ± 7 (8) b0.001 NS
LDL (mg/dL) 97 ± 28 (17) 63 ± 19 (8) NS 103 ± 28 (17) 68 ± 19 (8) 0.001 0.001
Dopamine (pg/mL) 56 ± 15 (17) 58 ± 17 (8) NS 57 ± 13 (17) 57 ± 11 (8) NS NS
Noradrenaline (pg/mL) 228 ± 77 (17) 220 ± 52 (8) NS 229 ± 85 (17) 217 ± 53 (8) NS NS
Adrenaline (pg/mL) 49 ± 15 (17) 45 ± 12 (8) NS 52 ± 15 (17) 43 ± 11 (8) NS NS
Adiponectin (ng/mL) 28 ± 6 (14) 37 ± 8 (8) NS 30 ± 9 (14) 39 ± 4 (7) NS NS
Phe, phenylalanine; Tyr, tyrosine; BCAA, branched chain amino acids (isoleucine, leucine, and valine); RER, respiratory exchange ratio; NS, non-signiﬁcant; N/A, not applicable. Results are
expressed as mean ± SD (n), two-sided paired t-test. After applying Bonferroni correction, only results with p b 0.002 were considered signiﬁcant (see methodology).
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To the best of our knowledge, this is the ﬁrst study to evaluate a con-
trolled aerobic exercise session in PKU patients and healthy individuals.
For that, we analyzed patients' basal metabolic status compared to con-
trols, aswell as their immediate responses to an aerobic exercise session
at the same relative intensity, whichwas calculated for each participant
by a previous VO2peak test. Our data corroborate the study by Grünert
et al. [23], where exercise did not change Phe concentrations acutely
in PKU patients. Moreover, we showed that metabolic responses to ex-
ercise are similar between PKU patients and controls, despite different
previous meal.
Our results were measured in a small number of patients of both
genders immediately after a 30-min exercise session that was per-
formed after a light breakfast. The small sample size is a limitation of
the study, thus making comparisons between subgroups of patients
very difﬁcult. That possibly contributed to the fact that most analyses
were not signiﬁcant in the group of patients. To counteract that, we
have included a greater number of controls, in a compatible ratio to
male and female patients. Due to the nature of the disease, PKU patients
and controls received distinct breakfasts, which varied in compositions,
thereby possibly causing different biochemical responses to exerciseFig. 2.Actual oxygen consumption (VO2) during the 30-min exercise in controls (CTL) and
well and poorly controlled phenylketonuria (PKU) patients. Data are expressed as
mean ± SD of percentage of prescribed VO2, n = 16 for controls, n = 5 and n = 3 for
well and poorly controlled PKU subgroups, respectively.[22,29]. The different meals represent real dietary habits of PKU and
non-PKU individuals, while studying the patients in fasting condition
would have caused other biochemical responses that had to be
prevented this way [23,30,31].
Regarding basal metabolic status, PKU patients showed similar BMR
values in comparison to controls. Some studies have found increased
basal metabolism in different diseases [32–35], although the mecha-
nisms are not yet elucidated. Despite that, our results agree with the
study by Allen et al. [36], where no differences in BMR were found
between early diagnosed PKU children and matched controls.
In rest and fasting (M1), patients showed lower BCAA and total
cholesterol levels in comparison with controls. Lower lipoprotein levels
and disturbed amino acid concentrations have been already described
in PKU children [37,38], being associated with the composition of the
Phe-restricted diet [11].
PKU patients have been encouraged to exercise [11,39], although its
efﬁcacy is not evidence-based. The concern on low physical activity
level for PKU patients has risen from data on bone density measure-
ments [7–9], as well as the eminent weight gain associated to consum-
ing Phe-free products, which are often rich in carbohydrates [10,11].
Obesity may become a spreading health issue of this era, and exercising
regularlymay also prevent overweight and its related disorders. Despite
that, the PKU patients of the present study showed normal BMI and
were so physically active as the controls, seen by the similar values ob-
served on VO2peak andworkload peak in the VO2peak test in both groups.
However, the three patients who showed the highest Phe values at M1
(poorly controlled), stayed slightly below the prescribed VO2 during the
exercise in average. This result did not reach statistical signiﬁcance
probably due to the small sample of patients. However, high Phe levels
impair executive functioning [2,27] that could, in turn, affect exercise
performance. In this way, patients that showed bad Phe control before
exercise seemed to have difﬁculties in keeping the prescribed VO2 dur-
ing cycling, even though being encouraged to do so.
Both patients and controls showed expected responses regarding
higher total cholesterol and LDL levels after exercise, since exercise en-
hances the availably of energetic substrates [40,41]. Tyr levels were in-
creased after exercise only in the control group. Grünert et al. [23]
have shown that Tyr levels increase immediately after aerobic exercise
in PKU patients. In that study, patients exercised during 20 min at
night (three hours after a dinner) making difﬁcult any comparison
with our ﬁndings, since in our study patients exercised during 30 min
at morning (shortly after a breakfast). Because of the different protein
sources of the breakfasts, our patients may have absorbed L-amino
acids from the metabolic formula faster than the controls had absorbed
casein from the yogurt [42]. Therefore, the effects of the breakfast for
59P.N. Mazzola et al. / Molecular Genetics and Metabolism Reports 5 (2015) 55–59patients might have been even more important with regard to amino
acids levels at M2. Nevertheless, the aerobic exercise in combination
with the amino acid-rich formula did not lead to unexpected metabolic
responses in PKU patients. In addition, RER levels were similar between
groups during basal condition and exercise. This result suggests that
high Phe levels and different dietary composition did not modify sub-
strate utilization in a small sample of treated patients with normal BMI.
5. Conclusions
Acute aerobic exercise followed by a Phe-restricted breakfast did not
change Phe concentrations in treated PKUpatients, but it is associated to
lower Phe/Tyr ratio only in controls. Future studies are needed to con-
ﬁrm our results in a higher number of patients, as well as controlling
for dietary intake before exercise.
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